Leighton-Swayze, Ann External Entity

Publications

Sort by

Selected publications

  • Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical trial.  Clinical cancer research : an official journal of the American Association for Cancer Research2015 Academic Article GET IT
    Times cited: 18

Other